Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Stock
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Park Ha Biological Technology Co., Ltd. Ordinary Shares
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
Park Ha Biological Technology Co., Ltd. Ordinary Shares is led by CEO Xiaoqiu Zhang, employs 31 people, headquartered in CN, publicly traded since 2025.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock trades at $0.35 with a market capitalization of $240227. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.32, price-to-sales of 0.06. Over the past 52 weeks the stock has ranged between $0.33 and $41.25, and currently trades 99.2% below its 52-week high.
On profitability, Park Ha Biological Technology Co., Ltd. Ordinary Shares generates a return on equity (ROE) of -174.17%, return on capital employed of -148.64%, an operating margin of -212.16%, a net profit margin of -214.17%.
Official website: www.parkha.cn/